The inhalation industry is evolving. Advances in in silico and AI-based technologies, sustainability drivers and a changing regulatory landscape are transforming device design and development. Against this backdrop, specialist contract development and manufacturing organisations (CDMOs) such as Bespak are in a unique position to get ahead of the curve by adopting the latest technologies to support their customers.
In our latest article in IPI (International Pharmaceutical Industry), key thought leaders at Bespak sat down to discuss inhalation device design and development capabilities at our King’s Lynn site and how these have evolved to meet industry needs. In this deep dive, we gathered insights from:
Shaun Williams, Product Engineering Manager
Karl Bass, Principal Model-Based Systems Engineer
Tony Mallett, Platform Development Group Manager
Thomas Daly, Development Engineer
Read the full article to discover how Bespak is shaping the future of inhalation device development.
